Screener
Hinge Health HNGE Deferred Commissions Current
Deferred Commissions Current at other companies
Other financials
Where this comes from
Reported directly by Hinge Health in its filing.
Tagged under the XBRL concept hnge:DeferredCommissionsCurrent.
The source filing: Hinge Health’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054327
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $286,224 | $207,995 |
| Short-term marketable securities | 103,167 | 155,867 |
| Accounts receivable, net of allowance for credit losses of $6,706 and $6,092 as of June 30, 2026 and December 31, 2025, respectively | 125,432 | 66,061 |
| Deferred commissions | 43,440 | 31,344 |
| Inventory | 16,769 | 15,636 |
| Prepaid expenses and other current assets | 68,321 | 57,001 |
| Total current assets | 643,353 | 533,904 |
| Long-term marketable securities | 84,742 | 113,172 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Hinge Health's deferred commissions current?
- Hinge Health (HNGE) reported deferred commissions current of $43.44M in Q2 2026.
- How has Hinge Health's deferred commissions current changed year-over-year?
- Hinge Health's deferred commissions current increased by 78.4% year-over-year, from $24.35M to $43.44M.
- What does deferred commissions current mean?
- Deferred Commissions Current as reported by Hinge Health, Inc..
Ask your AI about Hinge Health's deferred commissions current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude